Sort
82,697 grants matching “vaccine development”
Understanding Survival of Human Bone Marrow Long-Lived Plasma Cells
$932,432Frances Eun-Hyung Lee · Emory University · R01 · FY2018 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$932,430Ann R Falsey · University Of Rochester · UM1 · FY2024 · AI
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
$932,328David H Walker · University Of Texas Med Br Galveston · U54 · FY2009 · AI
IHV/UM AITRP IN THE CARIBBEAN, BRAZIL AND NIGERIA
$932,104University Of Maryland Baltimore · D43 · FY2001 · TW
SCH: INT: Surveillance and Control of Mosquito-Borne Diseases through Automated Species Identification and Spatiotemporal Modeling
$932,000Ryan M Carney · University Of South Florida · · FY2020 · CSE
Assessing Safety of Cell Substrates and Vaccine Components
$932,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$931,983Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2021 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$931,983Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2020 · AI
Salmonella Group C as part of a multivalent Salmonella vaccine
$931,897Sharon Mei Tennant · University Of Maryland Baltimore · U19 · FY2018 · AI
Modulation of Human Cells by Virulent Francisella tularensis
$931,662Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Molecular Genetics Of Scrapie Pathogenesis
$931,637Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Immune responses to HPV infection and HPV vaccination
$931,625Mahboobeh Safaeian · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
A universal MHC-E-restricted T cell vaccine for HIV
$931,503Jonah B. Sacha · Oregon Health & Science University · R01 · FY2018 · AI
HANTAVIRUS ECOLOGY AND DISEASE IN CHILE AND PANAMA
$931,499Gregory James Mertz · University Of New Mexico · U19 · FY2007 · AI
NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
$931,497Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Plant Viruses as Platforms for Biomaterials
$931,424Scripps Research Institute · R01 · FY2003 · EB
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
$931,391University Of Wisconsin Madison · R01 · FY2003 · AI
Project 1: Serology
$931,365Taia Wang · Stanford University · U54 · FY2020 · CA
Towards a New Generation of Glycoengineered Pneumococcal Bioconjugate Vaccines
$931,060Christian Harding · Vaxnewmo, Llc · R44 · FY2020 · AI
Defining Drivers of HPV-associated Carcinogenesis
$930,851Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2025 · CA
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
$930,504Jonah B. Sacha · Oregon Health & Science University · R01 · FY2021 · AI
Evaluating Whether a Concurrent Retinoid X Receptor Agonist can Enhance the Efficacy of the HER2-IGFPB2-IGF1R Vaccine in Eliminating Existing Ductal Carcinoma in Situ and Preventing Progression of Inv
$930,464Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA
Undetected Drug resistance and Tolerance in lesions of recurrent TB
$930,462Faramarz Valafar · San Diego State University · R01 · FY2025 · AI
Core B: Data Management
$930,430Luki Goldschmidt · University Of Washington · U19 · FY2024 · AI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings
$930,046Minmin Yen · Phagepro, Inc. · R44 · FY2023 · AI